63 companies

Incyte

Market Cap: US$25.9b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

INCY

US$127.98

7D

3.6%

1Y

51.0%

Exelixis

Market Cap: US$13.4b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$54.55

7D

4.3%

1Y

43.9%

Orion Oyj

Market Cap: €11.1b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€79.10

7D

1.3%

1Y

14.1%

CSPC Innovation Pharmaceutical

Market Cap: CN¥63.0b

Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.

New

300765

CN¥45.24

7D

1.8%

1Y

-16.6%

Shanghai Allist Pharmaceuticals

Market Cap: CN¥50.5b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

688578

CN¥112.19

7D

-6.5%

1Y

19.6%

Abbott India

Market Cap: ₹561.3b

Operates as a pharmaceutical company in India.

500488

₹26,415.85

7D

-1.9%

1Y

-16.2%

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥38.9b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

688336

CN¥43.45

7D

-10.9%

1Y

16.9%

3SBio

Market Cap: HK$44.6b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

1530

HK$17.90

7D

2.5%

1Y

-40.2%

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹496.4b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

500660

₹2,930.50

7D

8.5%

1Y

4.7%

ACADIA Pharmaceuticals

Market Cap: US$5.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

ACAD

US$29.65

7D

2.2%

1Y

17.1%

SK Biopharmaceuticals

Market Cap: ₩6.8t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

A326030

₩86,400.00

7D

-1.0%

1Y

-14.0%

Ajanta Pharma

Market Cap: ₹447.3b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

AJANTPHARM

₹3,579.90

7D

-3.7%

1Y

36.5%

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥31.2b

Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.

688266

CN¥117.83

7D

-3.5%

1Y

6.0%

Sumitomo Pharma

Market Cap: JP¥636.1b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

4506

JP¥1,418.00

7D

4.6%

1Y

-5.7%

Xiamen Amoytop Biotech

Market Cap: CN¥24.3b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

688278

CN¥59.47

7D

1.5%

1Y

-30.1%

Laboratorios Farmaceuticos Rovi

Market Cap: €3.1b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

ROVI

€59.85

7D

3.9%

1Y

2.7%

Neuland Laboratories

Market Cap: ₹294.1b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

524558

₹22,926.10

7D

-3.2%

1Y

69.3%

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س9.8b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

4015

ر.س139.70

7D

-0.1%

1Y

-11.3%

CareDx

Market Cap: US$2.5b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

CDNA

US$47.50

7D

2.4%

1Y

272.5%

ADMA Biologics

Market Cap: US$2.2b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$9.55

7D

2.2%

1Y

-43.9%

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥13.8b

Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.

300573

CN¥38.52

7D

-6.4%

1Y

-17.3%

HBM Holdings

Market Cap: HK$13.9b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

2142

HK$16.01

7D

8.2%

1Y

29.2%

Innoviva

Market Cap: US$1.5b

Operates as a biopharmaceutical company in the United States and internationally.

INVA

US$21.03

7D

0.3%

1Y

6.4%

MeiraGTx Holdings

Market Cap: US$1.4b

A clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases.

MGTX

US$14.83

7D

7.7%

1Y

95.6%

CORONA Remedies

Market Cap: ₹131.4b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

CORONA

₹2,149.00

7D

1.7%

1Y

n/a

ChemoMetec

Market Cap: DKK 8.5b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

CHEMM

DKK 487.00

7D

4.6%

1Y

-6.1%

BioGaia

Market Cap: SEK 11.8b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BIOG B

SEK 116.30

7D

1.0%

1Y

17.7%

Oscotec

Market Cap: ₩1.5t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

A039200

₩38,250.00

7D

2.3%

1Y

15.2%

Basilea Pharmaceutica

Market Cap: CHF 802.5m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

New

BSLN

CHF 64.70

7D

19.4%

1Y

38.5%

Soho Global Health

Market Cap: Rp15.2t

Together with its subsidiaires, operates as a healthcare company in Indonesia.

SOHO

Rp1,200.00

7D

2.1%

1Y

58.9%

Zevra Therapeutics

Market Cap: US$704.9m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

ZVRA

US$11.65

7D

1.0%

1Y

24.5%

CorMedix

Market Cap: US$639.1m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

CRMD

US$8.28

7D

8.0%

1Y

-39.7%

Rafa Laboratories

Market Cap: ₪1.5b

A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.

RAFA

₪15.09

7D

4.5%

1Y

n/a

DHG Pharmaceutical

Market Cap: ₫12.6t

Engages in the manufacture and sale of pharmaceutical products in Vietnam.

DHG

₫96,100.00

7D

2.8%

1Y

-4.7%

Onconic Therapeutics

Market Cap: ₩659.3b

Engages in the research and development of anti-cancer therapy in South Korea.

A476060

₩14,520.00

7D

-2.0%

1Y

135.1%

Q32 Bio

Market Cap: US$475.4m

A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.

QTTB

US$16.36

7D

2.6%

1Y

730.5%

Page 1 of 2